Blue Jet Healthcare
BLUEJET · Pharma > Pharmaceuticals & Drugs Listing date: Nov. 1, 2023

Stock Price vs Company Growth
1d
1.5%
1w
3.9%
1m
26.7%
3m
54.1%
6m
8.2%
1y
34.8%
all
14.7%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 570 1.5%
372
586
Company Overview

Sales
947 Cr
Growth: 0.8%
Profit after Tax
248 Cr
Growth: -15.6%
Mid Cap
9,896 Cr
P/E: 40.3x
Industry P/E: 33.7x
Fundamentals

Sales (Cr) ₹ 947
Growth 0.8%
EBITDA 31.0%
P/S 10.6x
Dividend 0.2%
P/E 40.3x
Book Value ₹ 78.4
PEG Ratio 52.0x
ROE 19.1%
P/B 7.2x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is a global, science-led, pharmaceutical company evolved as Strategic Partner for Collaboration, Development & Manufacturing of advance Pharmaceutical Intermediates and API.
Followers (1)